Trials / Active Not Recruiting
Active Not RecruitingNCT07229807
Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A
A Phase 3 Study of ZSP1273 in Otherwise Healthy Children 2-11 Years Old With Influenza A
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 119 (estimated)
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd · Industry
- Sex
- All
- Age
- 2 Years – 11 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted in China. The aim of the trial is to investigate safety and efficacy of ZSP1273 granules
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ZSP1273 | Oral |
| DRUG | Oseltamivir | Oral |
Timeline
- Start date
- 2025-11-22
- Primary completion
- 2025-12-17
- Completion
- 2025-12-31
- First posted
- 2025-11-17
- Last updated
- 2025-12-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07229807. Inclusion in this directory is not an endorsement.